Consumer Protection

  • September 30, 2024

    Smart Car Equipment Makers Call For C-V2X rules

    High-tech automakers are pushing the Federal Communications Commission to finalize cellular vehicle-to-everything rules, telling the commission that the wait for clear regulation has delayed the technology's rollout.

  • September 30, 2024

    Schwab Nears Deal In Antitrust Suit Over TD Ameritrade Buy

    Charles Schwab Corp. has reached "an agreement in principle" with retail investors who filed a proposed class action alleging increased transaction costs for trades and other antitrust injury following the Schwab-TD Ameritrade merger, the parties told a Texas federal judge Friday.

  • September 30, 2024

    GM Asks Full 6th Circ. To Rehear Transmission Defect Case

    General Motors LLC is asking the full Sixth Circuit to hold an en banc rehearing of a panel decision last month affirming class certification in a suit alleging it sold vehicles with defective transmissions that caused shaking and shuddering, saying the panel ignored precedent in allowing the class claims to go forward.

  • September 30, 2024

    Alaska Seeks Toss Of Challenge To New Hemp Regulations

    The state of Alaska is asking a federal court to throw out a bid by a hemp industry group to block enforcement of regulations prohibiting the sale of intoxicating hemp products, saying the regulations are not preempted by federal law.

  • September 30, 2024

    Steward Health CEO Sues Senate Panel After Contempt Vote

    The outgoing CEO of embattled Steward Health Care on Monday sued members of Congress who voted earlier this month to hold him in contempt for defying their subpoena to testify at a hearing into the downfall of the bankrupt hospital chain he heads.

  • September 30, 2024

    Epic Accuses Samsung Of Helping Google Block App Fix

    Epic Games filed a new federal lawsuit Monday against Google and Samsung, alleging the search giant and the phonemaker have teamed up "to preemptively undermine" a looming order forcing Google to permit competition with its Play Store.

  • September 30, 2024

    Helene-Hit NC Alters Court Deadlines, Flags Price-Gouging  

    Hurricane Helene's wrath in North Carolina prompted the extension of state court filing deadlines and price-gouging warnings by state and federal enforcers as the legal community grappled with what Chief Supreme Court Justice Paul Newby lamented as "catastrophic conditions" caused by the vicious storm.

  • September 27, 2024

    Binance Founder Zhao Released From Federal Custody

    Binance founder Changpeng Zhao was released from a California correctional facility Friday after he was sentenced to four months in prison for his failure to implement an effective anti-money laundering program at the global cryptocurrency exchange, the Federal Bureau of Prisons confirmed to Law360.

  • September 27, 2024

    'So What?': OnlyFans' Dismissal Bid Faces Skeptical Judge

    A San Francisco federal judge indicated Friday that he won't dismiss a proposed class action against OnlyFans' parent company alleging the video platform dupes customers into automatically renewing their subscriptions, waving away arguments that a Los Angeles federal judge dismissed a similar suit and asking its lawyers, "So what?"

  • September 27, 2024

    Bread's Banks Fork Over $2M To FDIC Over Rewards Issue

    The Federal Deposit Insurance Corp. has fined Bread Financial's Comenity bank units a total of $2 million as part of a pair of consent orders made public Friday that resolve unfair practices claims tied to their rewards programs and automatic payments processing.

  • September 27, 2024

    FCC Chief Quotes Taylor Swift In Tough Stance On Deepfakes

    Federal Communications Commission chairwoman Jessica Rosenworcel vowed during a speech Friday to take a strong position on enforcing the Telephone Consumer Protection Act against AI-generated robocalls and noted the FCC is considering new AI election-related disclosure regulations, quoting pop singer Taylor Swift who said, "The simplest way to combat misinformation is with the truth."

  • September 27, 2024

    Fla. Timeshare Biz Wins $1.3M Fee Award In False Ad Suit

    A Florida federal judge has awarded more than $1.3 million in attorney fees to a timeshare company that prevailed in a lawsuit against a Wyoming company over a false advertising scheme encouraging customers to stop paying for their properties, after agreeing the marketers pursued an "exceptionally weak case" that would not succeed.

  • September 27, 2024

    Claims Trimmed In Delaware Jeep Hybrid Defect Class Action

    A Delaware federal judge threw out a number of claims Friday from a proposed class action against automaker FCA US LLC alleging it sold Jeep Wrangler and Grand Cherokee plug-in hybrid vehicles with a defective feature that renders electric driving unavailable, adopting the bulk of a magistrate judge's report filed in July.

  • September 27, 2024

    SEC Fines Firms, Sues Ex-Reps' Over Cherry-Picking Scheme

    The U.S. Securities and Exchange Commission said Friday that Illinois-based Cetera Investment Advisers LLC and formerly California-based First Allied Advisory Services Inc. have each agreed to pay $200,000 to settle claims that two investment advisers formerly associated with both firms ran separate, multiyear, cherry-picking schemes that harmed investors.

  • September 27, 2024

    Banks Beat Credit Line Disclosure Suit After CFPB Weighs In

    An Illinois federal judge has thrown out a proposed class action accusing two Midwestern banks of failing to provide required repayment disclosures to borrowers, agreeing with the Consumer Financial Protection Bureau that these disclosures aren't actually required for the type of account at issue.

  • September 27, 2024

    9th Circ. Says Stem Cell Treatment Not Exempt From FDA Rule

    Two California clinics' experimental stem cell treatments are "drugs" subject to Food, Drug and Cosmetic Act regulations, the Ninth Circuit ruled Friday, reviving the federal government's bid to stop the clinic from marketing the products as cures for certain diseases without U.S. Food and Drug Administration review.

  • September 27, 2024

    Meta's Password Storage Flub Draws €91M Irish Fine

    Ireland's data protection authority has hit Facebook parent company Meta Platforms Inc. with a €91 million ($101.5 million) penalty for allegedly storing users' passwords without encryption or other necessary safeguards, the regulator announced Friday. 

  • September 27, 2024

    FTX Users Say Binance Manipulated Market To Spark Collapse

    Users of the now-defunct cryptocurrency exchange FTX told a Florida federal judge that social media posts by competing exchange Binance still manipulated markets to cause the collapse of FTX and harm users even if the statements themselves weren't false.

  • September 27, 2024

    Disney Wants FuboTV Tying Suit Tossed Before Trial

    Disney told a New York federal judge Thursday that FuboTV in its tying claims against the programming giant still hasn't shown how Disney's bundling practice is out of the ordinary, saying that similar bundles have existed for years and have been cleared by the courts and the Federal Communications Commision.

  • September 27, 2024

    RealPage Wants DOJ Antitrust Case Moved To Tennessee

    RealPage has asked a North Carolina federal court to transfer the government's antitrust case against it to Tennessee, where private litigation has been playing out over claims the software company helps residential landlords fix rental prices.

  • September 27, 2024

    Hemp Org., Cheech & Chong Take Aim At New Calif. THC Ban

    A leading hemp industry trade organization has teamed up with the cannabis brand fronted by stoner comedians Cheech and Chong to challenge new emergency regulations in California that ban the sale of hemp products containing the psychoactive cannabinoid THC.

  • September 27, 2024

    Why Many Drugs Remain Pricey 40 Years After Hatch-Waxman

    In the four decades since Congress passed the Hatch-Waxman Act in an effort to make generic drugs more available, the pharmaceutical industry has used patent thickets, "evergreening" and pay-for-delay tactics to block competition and keep prices of life-saving specialty drugs astronomical, several legal experts told Law360, while the industry argues other parties shoulder more of the blame.

  • September 27, 2024

    FCC Chief Says Chevron's Fall Won't Slow Needed Regs

    Upcoming Federal Communications Commission rules are likely to survive judicial scrutiny even after the Chevron doctrine's demise because the policies are grounded on not only legal analysis but in-depth economic and engineering studies, the agency's chief said Friday.

  • September 27, 2024

    L'Oréal Can't Turn Off Try-On Tool BIPA Suit

    An Illinois federal judge on Friday refused to dismiss a proposed class action accusing L'Oréal USA of violating Illinois' biometric privacy law with its virtual try-on tool, saying the beauty giant failed to give the plaintiff constructive notice of its arbitration terms and that she'd done enough at this stage to plausibly allege it collected her biometric identifiers.

  • September 27, 2024

    GM, LG Get Go-Ahead On $150M EV Battery Settlement

    A Michigan federal judge has given preliminary approval to a $150 million settlement to resolve claims that General Motors LLC sold Chevrolet Bolt electric vehicles with faulty batteries made by LG units, finding the deal to be fair and reasonable in resolving the claims.

Expert Analysis

  • Mirror, Mirror On The Wall, Is My Counterclaim Bound To Fall?

    Author Photo

    A Pennsylvania federal court’s recent dismissal of the defendants’ counterclaims in Morgan v. Noss should remind attorneys to avoid the temptation to repackage a claim’s facts and law into a mirror-image counterclaim, as this approach will often result in a waste of time and resources, says Matthew Selmasska at Kaufman Dolowich.

  • Loper Fuels Debate Over Merchant Cash Advances As Credit

    Author Photo

    The U.S. Supreme Court's recent rejection of the Chevron doctrine in Loper Bright may escalate a Florida federal court dispute between the Revenue Based Finance Coalition and the Consumer Financial Protection Bureau over whether merchant cash advances should be considered credit under the Dodd-Frank Act, say attorneys at Sheppard Mullin.

  • FTC's Drug Middlemen Probe Highlights Ongoing Scrutiny

    Author Photo

    The Federal Trade Commission's interim staff report on its inquiry into pharmacy benefit managers suggests that the industry will remain under an enforcement microscope for the foreseeable future due to concerns about how PBMs affect drug costs and accessibility, say attorneys at Arnold & Porter.

  • 6 Factors That Can Make For A 'Nuclear' Juror

    Author Photo

    Drawing from recent research that examines the rise in nuclear verdicts, Ken Broda-Bahm at Persuasion Strategies identifies a few juror characteristics most likely to matter in assessing case risk and preparing for jury selection — some of which are long-known, and others that are emerging post-pandemic.

  • Series

    Playing Dungeons & Dragons Makes Me A Better Lawyer

    Author Photo

    Playing Dungeons & Dragons – a tabletop role-playing game – helped pave the way for my legal career by providing me with foundational skills such as persuasion and team building, says Derrick Carman at Robins Kaplan.

  • A Look At The Regulatory Scrutiny Facing Liquid Restaking

    Author Photo

    Recent U.S. Securities and Exchange Commission enforcement actions highlight the regulatory challenges facing emerging financial instruments like liquid restaking tokens and services, say Daniel Davis and Alexander Kim at Katten.

  • Considerations When Using Publicly Available Data To Train AI

    Author Photo

    To maximize the benefits and mitigate the risks of using publicly available data to train artificial intelligence models, companies should maintain a balance between openness and protection, and consider certain best practices, says Michael Cole at Mercedes-Benz Research & Development North America.

  • Del. Dispatch: Director Caremark Claims Need Extreme Facts

    Author Photo

    The Delaware Court of Chancery recently dismissed Caremark claims against the directors of Centene in Bricklayers Pension Fund of Western Pennsylvania v. Brinkley, indicating a high bar for a finding of the required element of bad faith for Caremark liability, and stressing the need to resist hindsight bias, say attorneys at Fried Frank.

  • Illinois BIPA Reform Offers Welcome Relief To Businesses

    Author Photo

    Illinois' recent amendment to its Biometric Information Privacy Act limits the number of violations and damages a plaintiff can claim — a crucial step in shielding businesses from unintended legal consequences, including litigation risk and compliance costs, say attorneys at Taft.

  • Gilead Drug Ruling Creates Corporate Governance Dilemma

    Author Photo

    If upheld, a California state appellate court's decision — finding that Gilead is liable for delaying commercialization of a safer HIV drug to maximize profits on another drug — threatens to undermine long-standing rules of corporate law and exposes companies to liability for decisions based on sound business judgment, says Shireen Barday at Pallas.

  • Class Action Law Makes An LLC A 'Jurisdictional Platypus'

    Author Photo

    The applicability of Section 1332(d)(10) of the Class Action Fairness Act is still widely misunderstood — and given the ambiguous nature of limited liability companies, the law will likely continue to confound courts and litigants — so parties should be prepared for a range of outcomes, says Andrew Gunem at Strauss Borrelli.

  • Unpacking The Latest FTC Guidance On Multilevel Marketing

    Author Photo

    Branko Jovanovic and Monica Zhong at Edgeworth Economics discuss the Federal Trade Commission's recent advice for multilevel marketers on how MLMs should approach their income and earnings reports, including participants costs, typical proceeds and distributor gains.

  • 3 Leadership Practices For A More Supportive Firm Culture

    Author Photo

    Traditional leadership styles frequently amplify the inherent pressures of legal work, but a few simple, time-neutral strategies can strengthen the skills and confidence of employees and foster a more collaborative culture, while supporting individual growth and contribution to organizational goals, says Benjamin Grimes at BKG Leadership.

  • Attorneys Can Benefit From Reverse-Engineering Their Cases

    Author Photo

    Trial advocacy programs often teach lawyers to loosely track the progression of a lawsuit during preparation — case analysis, then direct examination, then cross-examination, openings and closings — but reverse-engineering cases by working backward from opening and closing statements can streamline the process and also improve case strategy, says Reuben Guttman at Guttman Buschner.

  • How Justices' E-Rate Decision May Affect Scope Of FCA

    Author Photo

    The U.S. Supreme Court’s eventual decision in Wisconsin Bell v. U.S., determining whether reimbursements paid by the E-rate program are "claims" under the False Claims Act, may affect other federal programs that do not require payments to be made by the U.S. Department of the Treasury, says David Colapinto at Kohn Kohn.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Consumer Protection archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!